A Look At Kare Schultz, The New CEO In Charge Of Teva
September 11, 2017 at 15:59 PM EDT
Kare Schultz, a veteran pharmaceutical executive with a background in restructuring, was a big hit with investors after the 56-year-old ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.